GLYCOPROTEIN PHARMACEUTICALS - SCIENTIFIC AND REGULATORY CONSIDERATIONS, AND THE UNITED-STATES ORPHAN DRUG-ACT

被引：61

作者：

LIU, DTY

机构：

来源：

关键词：

D O I：

10.1016/0167-7799(92)90192-X

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：114 / 120

页数：7

共 29 条

[1] ANFINSEN CB, 1968, 27TH S SOC DEV BIOL, V2, P1
[2] ASHWELL G., 1971, GLYCOPROTEINS BLOOD, P173
[3] PITUITARY GLYCOPROTEIN HORMONE OLIGOSACCHARIDES - STRUCTURE, SYNTHESIS AND FUNCTION OF THE ASPARAGINE-LINKED OLIGOSACCHARIDES ON LUTROPIN, FOLLITROPIN AND THYROTROPIN
BAENZIGER, JU
GREEN, ED
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 947 (02) : 287 - 306
[4] BERKOWER I, 1991, REPROT WORKSHOP MICR
[5] BROWNE MJ, 1988, J BIOL CHEM, V263, P1599
[6] CLAMP JR, 1974, BIOCHEM SOC S, V40, P3
[7] COLLEN D, 1984, J PHARMACOL EXP THER, V231, P146
[8] CUMMING D A, 1991, Glycobiology, V1, P115, DOI 10.1093/glycob/1.2.115
[9] DANAHUE RE, 1986, COLD SPRING HARB SYM, V51, P685
[10] DOUSHAL GP, 1988, BIOCH PLANT, V14, P421